Company profile

Ticker
ABT
Exchange
CEO
Miles D. White
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
360698440

ABT stock data

(
)

Calendar

1 May 19
18 Jun 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Mar 19 Dec 18 Sep 18 Jun 18
Revenue 7.54B 7.77B 7.66B 7.77B
Net income 672M 654M 563M 733M
Diluted EPS 0.38 0.37 0.32 0.41
Net profit margin 8.92% 8.42% 7.35% 9.44%
Operating income 739M 1.17B 995M 882M
Net change in cash -822M -3.53B 4.3B -792M
Cash on hand 3.02B 3.84B 7.37B 3.07B
Cost of revenue 3.16B 3.19B 3.17B 3.28B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 30.58B 27.39B 20.85B 20.41B
Net income 2.37B 477M 1.4B 4.42B
Diluted EPS 1.33 0.27 0.94 2.92
Net profit margin 7.74% 1.74% 6.71% 21.68%
Operating income 3.65B 1.56B 3.03B 2.87B
Net change in cash -5.56B -9.21B 13.62B 938M
Cash on hand 3.84B 9.41B 18.62B 5B
Cost of revenue 12.71B 12.41B 9.09B 8.75B

Financial data from company earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Bad
New words: achieving, Africa, Alinity, assessing, atrial, balloon, basically, book, borrowing, carotid, CE, Cephea, contact, Cut, decline, direct, Enabled, endovascular, family, fibrillation, flat, flu, force, grew, heartbeat, implicit, invasive, irregular, largest, leaky, lease, leased, lessee, life, methodology, minimally, MOMENTUM, negative, negatively, NGO, option, organization, package, PediaSure, peripheral, platform, policy, population, pump, randomized, reagent, ROU, royalty, season, secondary, Similac, space, supplied, TactiCath, TM, trial, valve
Removed: AbbVie, acquire, Additionally, agency, agreed, alternative, AMO, analyze, application, applying, appraisal, area, assay, assumed, attributable, August, Beckman, bridge, capitalized, cashed, CGM, chronic, classified, classify, close, closed, closing, combined, combining, comparative, complexity, Confirm, Convertible, Coulter, country, curtailment, cycle, depending, designation, determining, develop, developed, discrete, diverse, divest, divestiture, drug, duration, effort, eliminated, eluting, employed, enacted, entitled, Epocal, equal, equaled, equated, estimating, evaluate, evaluating, exclude, expansion, expiration, expired, facility, Femoseal, formed, fourth, fund, global, guidance, hand, hedging, Historically, hold, Holding, ICM, identical, identifiable, identification, identify, ii, important, improvement, Improving, infant, Insertable, invoicing, issuer, Japan, Johnson, judgment, July, lag, launch, leader, legacy, legislation, liable, liquidation, loan, low, manufacturer, marketable, maximum, measured, medium, MeterPro, model, Monitor, movement, multiple, Mylan, national, Natriuretic, nonperformance, November, nutrition, obtaining, occurrence, offer, offered, ongoing, orderly, ordinary, pain, Peptide, performed, Perpetual, personnel, post, preference, preferred, presence, presentation, principle, promised, properly, proprietary, provisional, qualify, qualifying, Quidel, ratably, rebate, recently, reclassification, reclassify, reconciling, refinanced, regulatory, reimbursement, reliable, reliably, remained, remeasurement, remotely, renewing, repaid, replacement, restatement, retained, retrospectively, return, revolving, routine, run, RxTM, satisfaction, satisfied, senior, separate, separation, set, settlement, Sheath, shipment, sourced, standalone, statutory, Steerable, stent, stranded, strong, subsequently, subsidiary, subtotal, tangible, Targeted, taxed, tender, tendered, termination, Terumo, Topic, toxicology, transaction, transfer, transmitter, Triage, type, unchanged, unpaid, unsecured, unused, utilized, Vado, validly, volume, weaker, withdrawn